Rankings
▼
Calendar
PTCT FY 2023 Earnings — PTC Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
PTCT
PTC Therapeutics, Inc.
$6B
FY 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$938M
+34.2% YoY
Gross Profit
$872M
93.0% margin
Operating Income
-$440M
-46.9% margin
Net Income
-$627M
-66.8% margin
EPS (Diluted)
$-8.37
Cash Flow
Operating Cash Flow
-$158M
Free Cash Flow
-$279M
Stock-Based Comp.
$131M
Balance Sheet
Total Assets
$1.9B
Total Liabilities
$2.7B
Stockholders' Equity
-$819M
Cash & Equivalents
$594M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$938M
$699M
+34.2%
Gross Profit
$872M
$654M
+33.4%
Operating Income
-$440M
-$447M
+1.8%
Net Income
-$627M
-$559M
-12.1%
← Q4 2022
All Quarters
Q1 2023 →